Vigonvita Life Sciences Co., Ltd.
Status: Publicly traded
Direct answer
Vigonvita Life Sciences Co., Ltd. is publicly traded on HKSE under the ticker 2630.HK.
Vigonvita Life Sciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas. Its products include LV232, a first-in-class dual-target 5-HTT/5-HT modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5...
Can you invest in Vigonvita Life Sciences Co., Ltd.?
Yes. Vigonvita Life Sciences Co., Ltd. trades publicly on HKSE as 2630.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vigonvita Life Sciences Co., Ltd.
Detailed equity research is provided by MarketSnap.